Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 4
2006 2
2007 2
2008 4
2009 1
2010 3
2011 5
2012 2
2013 2
2014 5
2015 8
2016 4
2017 3
2018 2
2019 1
2020 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

48 results
Results by year
Filters applied: . Clear all
Page 1
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.
Lange P, Celli B, Agustí A, Boje Jensen G, Divo M, Faner R, Guerra S, Marott JL, Martinez FD, Martinez-Camblor P, Meek P, Owen CA, Petersen H, Pinto-Plata V, Schnohr P, Sood A, Soriano JB, Tesfaigzi Y, Vestbo J. Lange P, et al. N Engl J Med. 2015 Jul 9;373(2):111-22. doi: 10.1056/NEJMoa1411532. N Engl J Med. 2015. PMID: 26154786 Free article.
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is thought to result from an accelerated decline in forced expiratory volume in 1 second (FEV1) over time. ...METHODS: We stratified participants in three independent cohorts (the F …
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is thought to result from an accelerated decline …
A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy.
Mapel D, Laliberté F, Roberts MH, Sama SR, Sundaresan D, Pilon D, Lefebvre P, Duh MS, Patel J. Mapel D, et al. Int J Chron Obstruct Pulmon Dis. 2017 Jun 21;12:1825-1836. doi: 10.2147/COPD.S129007. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28684905 Free PMC article.
INTRODUCTION: An incremental approach using open-triple therapy may improve outcomes in patients with chronic obstructive pulmonary disease (COPD). However, there is little sufficient, real-world evidence available identifying time to open-tripl …
INTRODUCTION: An incremental approach using open-triple therapy may improve outcomes in patients with chronic obstructive p
Chronic obstructive pulmonary disease mortality, a competing risk analysis.
Abukhalaf J, Davidson R, Villalobos N, Meek P, Petersen H, Sood A, Tesfaigzi Y, Vazquez Guillamet R. Abukhalaf J, et al. Clin Respir J. 2018 Nov;12(11):2598-2605. doi: 10.1111/crj.12963. Epub 2018 Oct 25. Clin Respir J. 2018. PMID: 30257066
BACKGROUND: Current risk factors for Chronic Obstructive Pulmonary Disease mortality focus only on overall and respiratory death. We investigated whether risk factors for each specific cause of mortality are different depending on the outcome under con …
BACKGROUND: Current risk factors for Chronic Obstructive Pulmonary Disease mortality focus only on overall and r …
Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts.
Castaldi PJ, Benet M, Petersen H, Rafaels N, Finigan J, Paoletti M, Marike Boezen H, Vonk JM, Bowler R, Pistolesi M, Puhan MA, Anto J, Wauters E, Lambrechts D, Janssens W, Bigazzi F, Camiciottoli G, Cho MH, Hersh CP, Barnes K, Rennard S, Boorgula MP, Dy J, Hansel NN, Crapo JD, Tesfaigzi Y, Agusti A, Silverman EK, Garcia-Aymerich J. Castaldi PJ, et al. Thorax. 2017 Nov;72(11):998-1006. doi: 10.1136/thoraxjnl-2016-209846. Epub 2017 Jun 21. Thorax. 2017. PMID: 28637835 Free PMC article.
BACKGROUND: COPD is a heterogeneous disease, but there is little consensus on specific definitions for COPD subtypes. ...CONCLUSIONS: Identical clustering analyses across multiple COPD cohorts showed modest reproducibility. COPD heterogen …
BACKGROUND: COPD is a heterogeneous disease, but there is little consensus on specific definitions for COPD subtypes. . …
Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer.
Tessema M, Yingling CM, Picchi MA, Wu G, Liu Y, Weissfeld JL, Siegfried JM, Tesfaigzi Y, Belinsky SA. Tessema M, et al. J Thorac Oncol. 2015 Aug;10(8):1181-8. doi: 10.1097/JTO.0000000000000592. J Thorac Oncol. 2015. PMID: 26200272 Free PMC article.

INTRODUCTION: Lung cancer and chronic obstructive pulmonary disease (COPD) share environmental risk factors. ...CCDC37 methylation was more prevalent in sputum from COPD than non-COPD smokers (p < 0.005) from two cohorts.

INTRODUCTION: Lung cancer and chronic obstructive pulmonary disease (COPD) share environmental risk facto …
A genome-wide association study of chronic obstructive pulmonary disease in Hispanics.
Chen W, Brehm JM, Manichaikul A, Cho MH, Boutaoui N, Yan Q, Burkart KM, Enright PL, Rotter JI, Petersen H, Leng S, Obeidat M, Bossé Y, Brandsma CA, Hao K, Rich SS, Powell R, Avila L, Soto-Quiros M, Silverman EK, Tesfaigzi Y, Barr RG, Celedón JC. Chen W, et al. Ann Am Thorac Soc. 2015 Mar;12(3):340-8. doi: 10.1513/AnnalsATS.201408-380OC. Ann Am Thorac Soc. 2015. PMID: 25584925 Free PMC article.
RATIONALE: Genome-wide association studies (GWAS) of chronic obstructive pulmonary disease (COPD) have identified disease-susceptibility loci, mostly in subjects of European descent. ...We performed a replication study of the top s …
RATIONALE: Genome-wide association studies (GWAS) of chronic obstructive pulmonary disease (COPD) …
Plasma metabolomics and clinical predictors of survival differences in COPD patients.
Pinto-Plata V, Casanova C, Divo M, Tesfaigzi Y, Calhoun V, Sui J, Polverino F, Priolo C, Petersen H, de Torres JP, Marin JM, Owen CA, Baz R, Cordova E, Celli B. Pinto-Plata V, et al. Respir Res. 2019 Oct 15;20(1):219. doi: 10.1186/s12931-019-1167-y. Respir Res. 2019. PMID: 31615518 Free PMC article.
BACKGROUND: Plasma metabolomics profile (PMP) in COPD has been associated with clinical characteristics, but PMP's relationship to survival has not been reported. ...METHODS: We studied prospectively 90 patients with severe COPD and 30 controls. NS were divid …
BACKGROUND: Plasma metabolomics profile (PMP) in COPD has been associated with clinical characteristics, but PMP's relationshi …
Impact of a Positive Viral Polymerase Chain Reaction on Outcomes of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations.
Gunasekaran K, Ahmad M, Rehman S, Thilagar B, Gopalratnam K, Ramalingam S, Paramasivam V, Arora A, Chandran A. Gunasekaran K, et al. Int J Environ Res Public Health. 2020 Nov 2;17(21):8072. doi: 10.3390/ijerph17218072. Int J Environ Res Public Health. 2020. PMID: 33147795 Free PMC article.
INTRODUCTION: More than 15 million adults in the USA have chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease (COPD) places a high burden on the healthcare system. ...RESULTS: There were 1626 …
INTRODUCTION: More than 15 million adults in the USA have chronic obstructive pulmonary disease. Chronic
Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data.
Stanford RH, Nag A, Mapel DW, Lee TA, Rosiello R, Vekeman F, Gauthier-Loiselle M, Duh MS, Merrigan JF, Schatz M. Stanford RH, et al. Ann Am Thorac Soc. 2016 Jul;13(7):1067-75. doi: 10.1513/AnnalsATS.201508-493OC. Ann Am Thorac Soc. 2016. PMID: 27070274
RATIONALE: Current chronic obstructive pulmonary disease (COPD) exacerbation risk prediction models are based on clinical data not easily accessible to national quality-of-care organizations and payers. ...OBJECTIVES: This study aimed to validat …
RATIONALE: Current chronic obstructive pulmonary disease (COPD) exacerbation risk prediction models are b …
Trends in Prevalence and Outcomes of Cannabis Use Among Chronic Obstructive Pulmonary Disease Hospitalizations: A Nationwide Population-Based Study 2005-2014.
Gunasekaran K, Voruganti DC, Singh Rahi M, Elango K, Ramalingam S, Geeti A, Kwon J. Gunasekaran K, et al. Cannabis Cannabinoid Res. 2021 Aug;6(4):340-348. doi: 10.1089/can.2020.0133. Epub 2021 Feb 15. Cannabis Cannabinoid Res. 2021. PMID: 33998884
Background: Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of mortality in the United States. ...The majority of COPD hospitalizations with cannabis use were aged 50-64 (60%). Cannabis use was associated with low …
Background: Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of mortality in the …
48 results